Status:
COMPLETED
Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
High Risk for Breast Cancer
Eligibility:
FEMALE
25+ years
Phase:
NA
Brief Summary
In the United States, carriers of hereditary genetic mutations have up to an 85% risk of developing breast cancer compared to 12% in the general population. Overall uptake of genetic services is gener...
Detailed Description
Study Design. The investigator will conduct a randomized control trial single-blind control trial to test the effectiveness of a culturally targeted decision aid video to promote genetic counseling am...
Eligibility Criteria
Inclusion
- Are female
- Identify as African American
- Are age 25 or older
- Speak and understand English
- Completed a cancer genetic risk assessment (CGRA) as part of clinic intake
- Are classified as high risk for developing breast cancer per CGRA
- Have not previously received genetic counseling
Exclusion
- Are not female
- Do not identify as African American
- Are age 24 or younger
- Do not speak and understand English
- Did not complete a cancer genetic risk assessment (CGRA) as part of clinic intake
- Are not classified as high risk for developing breast cancer per CGRA
- Have previously received genetic counseling
Key Trial Info
Start Date :
June 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04378751
Start Date
June 6 2023
End Date
May 31 2025
Last Update
August 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UIC Cancer Center
Chicago, Illinois, United States, 60612
2
University of Illinois at Chicago Hospital and Ambulatory Clinics
Chicago, Illinois, United States, 60612